<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39346684</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2516-8290</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>9</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Access microbiology</Title><ISOAbbreviation>Access Microbiol</ISOAbbreviation></Journal><ArticleTitle>The Y498T499-SARS-CoV-2 spike (S) protein interacts poorly with rat ACE2 and does not affect the rat lung.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">000839.v3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1099/acmi.0.000839.v3</ELocationID><Abstract><AbstractText>The rat is a useful laboratory model for respiratory diseases. SARS-CoV-2 proteins, such as the spike (S) protein, can induce inflammation. This study has investigated the ability of the Q498Y, P499T (QP-YT) amino acid change, described in the S-protein of the mouse-adapted laboratory SARS-CoV-2 MA strain, to interact with rat angiotensin converting enzyme-2 (ACE2) and stimulate responses in rat lungs. A real-time S-ACE2 quantitative fusion assay shows that ancestral and L452R S-proteins fuse with human but not rat ACE2 expressed on HEK293 (human embryonic kidney-293) cells. The QP-YT S-protein retains the ability to fuse with human ACE2 and increases the binding to rat ACE2. Although lower lung of the rat contains both ACE2 and TMPRSS2 (transmembrane serine protease 2) target cells, intratracheal delivery of ancestral or QP-YT S-protein pseudotyped lentivirus did not induce measurable respiratory changes, inflammatory infiltration or innate mRNA responses. Isolation of primary cells from rat alveoli demonstrated the presence of cells expressing ACE2 and TMPRSS2. Infection of these cells, however, with ancestral or QP-YT S-protein pseudotyped lentivirus was not observed, and the QP-YT S-protein pseudotyped lentivirus poorly infected HEK293 cells expressing rat ACE2. Analysis of the amino acid changes across the S-ACE2 interface highlights not only the Y498 interaction with H353 as a likely facilitator of binding to rat ACE2 but also other amino acids that could improve this interaction. Thus, rat lungs contain cells expressing receptors for SARS-CoV-2, and the QP-YT S-protein variant can bind to rat ACE2, but this does not result in infection or stimulate responses in the lung. Further, amino acid changes in S-protein may enhance this interaction to improve the utility of the rat model for defining the role of the S-protein in driving lung inflammation.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Amy L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0009-0001-8698-1836</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flinders Health and Medical Research Institute, Flinders University, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Bellis</LastName><ForeName>Dylan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2741-7004</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowell</LastName><ForeName>Evangeline</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2492-135X</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flinders Health and Medical Research Institute, Flinders University, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenchine</LastName><ForeName>Roman V</ForeName><Initials>RV</Initials><Identifier Source="ORCID">0000-0002-8947-1030</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flinders Health and Medical Research Institute, Flinders University, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penn</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0005-3960-0817</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flinders Health and Medical Research Institute, Flinders University, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kris</LastName><ForeName>Luke P</ForeName><Initials>LP</Initials><Identifier Source="ORCID">0000-0002-2257-6874</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flinders Health and Medical Research Institute, Flinders University, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McEvoy-May</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2450-1267</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bihari</LastName><ForeName>Shailesh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7553-8620</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dixon</LastName><ForeName>Dani-Louise</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0001-6459-1856</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>Jillian M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-1080-1472</Identifier><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flinders Health and Medical Research Institute, Flinders University, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Access Microbiol</MedlineTA><NlmUniqueID>101746927</NlmUniqueID><ISSNLinking>2516-8290</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">lentivirus pseudotype</Keyword><Keyword MajorTopicYN="N">rat</Keyword><Keyword MajorTopicYN="N">respiratory mechanics</Keyword><Keyword MajorTopicYN="N">spike protein</Keyword></KeywordList><CoiStatement>The authors declare that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39346684</ArticleId><ArticleId IdType="pmc">PMC11432600</ArticleId><ArticleId IdType="doi">10.1099/acmi.0.000839.v3</ArticleId><ArticleId IdType="pii">000839.v3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141–154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Wu Y, Zhong P, Hou B, Liu J, et al. A clinical staging proposal of the disease course over time in non-severe patients with coronavirus disease 2019. Sci Rep. 2021;11:10681. doi: 10.1038/s41598-021-90111-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90111-y</ArticleId><ArticleId IdType="pmc">PMC8140110</ArticleId><ArticleId IdType="pubmed">34021206</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Hilgenfeld R, Whitley R, De Clercq E. Therapeutic strategies for COVID-19: progress and lessons learned. Nat Rev Drug Discov. 2023;22:449–475. doi: 10.1038/s41573-023-00672-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-023-00672-y</ArticleId><ArticleId IdType="pmc">PMC10113999</ArticleId><ArticleId IdType="pubmed">37076602</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Zhao H, Espín E, Tebbutt SJ. Association of SARS-CoV-2 infection and persistence with long COVID. Lancet Respir Med. 2023;11:504–506. doi: 10.1016/S2213-2600(23)00142-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00142-X</ArticleId><ArticleId IdType="pmc">PMC10171832</ArticleId><ArticleId IdType="pubmed">37178694</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon KH, III, Leist SR, Schäfer A, Edwards CE, Martinez DR, et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 2020;586:560–566. doi: 10.1038/s41586-020-2708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2708-8</ArticleId><ArticleId IdType="pmc">PMC8034761</ArticleId><ArticleId IdType="pubmed">32854108</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Xie Y, Bai B, Luo C, Zhou J, et al. Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variants. Nat Commun. 2023;14:4405. doi: 10.1038/s41467-023-39942-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39942-z</ArticleId><ArticleId IdType="pmc">PMC10362042</ArticleId><ArticleId IdType="pubmed">37479708</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai H, Chan JF-W, Yuen TT-T, Yoon C, Hu J-C, et al. Emerging SARS-CoV-2 variants expand species tropism to murines. EBioMedicine. 2021;73:103643. doi: 10.1016/j.ebiom.2021.103643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103643</ArticleId><ArticleId IdType="pmc">PMC8530107</ArticleId><ArticleId IdType="pubmed">34689086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Lenoch J, Kohler D, DeLiberto TJ, Tang CY, et al. SARS-CoV-2 exposure in Norway rats (Rattus norvegicus) from New York city. mBio. 2023;14:e0362122. doi: 10.1128/mbio.03621-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.03621-22</ArticleId><ArticleId IdType="pmc">PMC10127689</ArticleId><ArticleId IdType="pubmed">36892291</ArticleId></ArticleIdList></Reference><Reference><Citation>Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295:L379–L399. doi: 10.1152/ajplung.00010.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00010.2008</ArticleId><ArticleId IdType="pmc">PMC2536793</ArticleId><ArticleId IdType="pubmed">18621912</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Shafiei MS, Longoria C, Schoggins JW, Savani RC, et al. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway. eLife. 2021;10:e68563. doi: 10.7554/eLife.68563.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S, Bao C, Yang Z, Liu S, Sun Y, et al. SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy. Signal Transduct Target Ther. 2023;8:108. doi: 10.1038/s41392-023-01368-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01368-w</ArticleId><ArticleId IdType="pmc">PMC9998025</ArticleId><ArticleId IdType="pubmed">36894537</ArticleId></ArticleIdList></Reference><Reference><Citation>Puthia M, Tanner L, Petruk G, Schmidtchen A. Experimental model of pulmonary inflammation induced by SARS-CoV-2 spike protein and endotoxin. ACS Pharmacol Transl Sci . 2022;5:141–148. doi: 10.1021/acsptsci.1c00219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsptsci.1c00219</ArticleId><ArticleId IdType="pmc">PMC9239546</ArticleId><ArticleId IdType="pubmed">35774232</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles JP, Zamora M, Adan-Castro E, Siqueiros-Marquez L, Martinez de la Escalera G, et al. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling. J Biol Chem. 2022;298:101695. doi: 10.1016/j.jbc.2022.101695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.101695</ArticleId><ArticleId IdType="pmc">PMC8820157</ArticleId><ArticleId IdType="pubmed">35143839</ArticleId></ArticleIdList></Reference><Reference><Citation>Montezano AC, Camargo LL, Mary S, Neves KB, Rios FJ, et al. SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. Sci Rep. 2023;13:14086. doi: 10.1038/s41598-023-41115-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-41115-3</ArticleId><ArticleId IdType="pmc">PMC10462711</ArticleId><ArticleId IdType="pubmed">37640791</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L, Morigi M, Pezzotta A, Locatelli M, Imberti B, et al. SARS-CoV-2 spike protein induces lung endothelial cell dysfunction and thrombo-inflammation depending on the C3a/C3a receptor signalling. Sci Rep. 2023;13:11392. doi: 10.1038/s41598-023-38382-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-38382-5</ArticleId><ArticleId IdType="pmc">PMC10349115</ArticleId><ArticleId IdType="pubmed">37452090</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirato K, Kizaki T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon. 2021;7:e06187. doi: 10.1016/j.heliyon.2021.e06187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e06187</ArticleId><ArticleId IdType="pmc">PMC7887388</ArticleId><ArticleId IdType="pubmed">33644468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, Gao H, Guo F, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875–879. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Sun PD. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity. J Biol Chem. 2020;295:18579–18588. doi: 10.1074/jbc.RA120.015303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.015303</ArticleId><ArticleId IdType="pmc">PMC7833600</ArticleId><ArticleId IdType="pubmed">33122196</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zeng Z, Cao Y, Liu Y, Ping F, et al. Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways. Sci Rep. 2016;6:27911. doi: 10.1038/srep27911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27911</ArticleId><ArticleId IdType="pmc">PMC4908402</ArticleId><ArticleId IdType="pubmed">27302421</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford KHD, Eguia R, Dingens AS, Loes AN, Malone KD, et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses. 2020;12:513. doi: 10.3390/v12050513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12050513</ArticleId><ArticleId IdType="pmc">PMC7291041</ArticleId><ArticleId IdType="pubmed">32384820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bihari S, Costell MH, Bouchier T, Behm DJ, Burgert M, et al. Evaluation of GSK2789917-induced TRPV4 inhibition in animal models of fluid induced lung injury. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:3461–3475. doi: 10.1007/s00210-023-02821-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-023-02821-x</ArticleId><ArticleId IdType="pubmed">37966569</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ. Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189–1191. doi: 10.1093/bioinformatics/btp033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp033</ArticleId><ArticleId IdType="pmc">PMC2672624</ArticleId><ArticleId IdType="pubmed">19151095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Ge J, Yu J, Shan S, Zhou H, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215–220. doi: 10.1038/s41586-020-2180-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Wu C, Cao X, Gu C, Liu H, et al. Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins. Cell Res. 2022;32:609–620. doi: 10.1038/s41422-022-00672-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-022-00672-4</ArticleId><ArticleId IdType="pmc">PMC9152305</ArticleId><ArticleId IdType="pubmed">35641567</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296–W303. doi: 10.1093/nar/gky427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky427</ArticleId><ArticleId IdType="pmc">PMC6030848</ArticleId><ArticleId IdType="pubmed">29788355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez C, Boelens R, Bonvin AMJJ. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc. 2003;125:1731–1737. doi: 10.1021/ja026939x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja026939x</ArticleId><ArticleId IdType="pubmed">12580598</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert GCP, Rodrigues JPGLM, Trellet M, Schmitz C, Kastritis PL, et al. The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J Mol Biol. 2016;428:720–725. doi: 10.1016/j.jmb.2015.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.09.014</ArticleId><ArticleId IdType="pubmed">26410586</ArticleId></ArticleIdList></Reference><Reference><Citation>Motozono C, Toyoda M, Zahradnik J, Saito A, Nasser H, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124–1136. doi: 10.1016/j.chom.2021.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.06.006</ArticleId><ArticleId IdType="pmc">PMC8205251</ArticleId><ArticleId IdType="pubmed">34171266</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A. 1993;90:8033–8037. doi: 10.1073/pnas.90.17.8033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.17.8033</ArticleId><ArticleId IdType="pmc">PMC47282</ArticleId><ArticleId IdType="pubmed">8396259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Cui H, Li E, Guo Z, Wang T, et al. The SARS-CoV-2 B.1.351 variant can transmit in rats but not in mice. Front Immunol. 2022;13:869809. doi: 10.3389/fimmu.2022.869809.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.869809</ArticleId><ArticleId IdType="pmc">PMC9095975</ArticleId><ArticleId IdType="pubmed">35572504</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23:3–20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Leist SR, Dinnon KH, III, Schäfer A, Tse LV, Okuda K, et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell. 2020;183:1070–1085. doi: 10.1016/j.cell.2020.09.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.050</ArticleId><ArticleId IdType="pmc">PMC7510428</ArticleId><ArticleId IdType="pubmed">33031744</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan K, Dumenil T, Tang B, Le TT, Bishop CR, et al. Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2. Virus Evol. 2022;8:veac063. doi: 10.1093/ve/veac063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac063</ArticleId><ArticleId IdType="pmc">PMC9338707</ArticleId><ArticleId IdType="pubmed">35919871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawle DJ, Le TT, Dumenil T, Yan K, Tang B, et al. ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions. PLoS Pathog. 2021;17:e1009723. doi: 10.1371/journal.ppat.1009723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009723</ArticleId><ArticleId IdType="pmc">PMC8282004</ArticleId><ArticleId IdType="pubmed">34214142</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Verma A, Li P, Ortiz ME, Hawkins GM, et al. Adaptation of SARS-CoV-2 to ACE2H353K mice reveals new spike residues that drive mouse infection. J Virol. 2024;98:e0151023. doi: 10.1128/jvi.01510-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01510-23</ArticleId><ArticleId IdType="pmc">PMC10804960</ArticleId><ArticleId IdType="pubmed">38168680</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakandakari-Higa S, Parsa R, Reis BS, de Carvalho RVH, Mesin L, et al. A minimally-edited mouse model for infection with multiple SARS-CoV-2 strains. Front Immunol. 2022;13:1007080. doi: 10.3389/fimmu.2022.1007080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1007080</ArticleId><ArticleId IdType="pmc">PMC9703079</ArticleId><ArticleId IdType="pubmed">36451809</ArticleId></ArticleIdList></Reference><Reference><Citation>Hörnich BF, Großkopf AK, Schlagowski S, Tenbusch M, Kleine-Weber H, et al. SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in their requirements for receptor expression and proteolytic activation. J Virol. 2021;95:e00002-21. doi: 10.1128/JVI.00002-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00002-21</ArticleId><ArticleId IdType="pmc">PMC8104116</ArticleId><ArticleId IdType="pubmed">33608407</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng B, Abdullahi A, Ferreira IATM, Goonawardane N, Saito A, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603:706–714. doi: 10.1038/s41586-022-04474-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04474-x</ArticleId><ArticleId IdType="pmc">PMC8942856</ArticleId><ArticleId IdType="pubmed">35104837</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasser H, Shimizu R, Ito J, Genotype to Phenotype Japan (G2P-Japan) Consortium. Saito A, et al. Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay. STAR Protoc. 2022;3:101773. doi: 10.1016/j.xpro.2022.101773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2022.101773</ArticleId><ArticleId IdType="pmc">PMC9510062</ArticleId><ArticleId IdType="pubmed">36313538</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajah MM, Hubert M, Bishop E, Saunders N, Robinot R, et al. SARS-CoV-2 alpha, beta, and delta variants display enhanced Spike-mediated syncytia formation. EMBO J. 2021;40:e108944. doi: 10.15252/embj.2021108944.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108944</ArticleId><ArticleId IdType="pmc">PMC8646911</ArticleId><ArticleId IdType="pubmed">34601723</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng R, Wu LA, Wang Q, Qi J, Gao GF. Cell entry by SARS-CoV-2. Trends Biochem Sci. 2021;46:848–860. doi: 10.1016/j.tibs.2021.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2021.06.001</ArticleId><ArticleId IdType="pmc">PMC8180548</ArticleId><ArticleId IdType="pubmed">34187722</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J, Li S, Zhang Y, Zheng J, Wang D, et al. Early emerging SARS-CoV-2 spike mutants are diversified in virologic properties but elicit compromised antibody responses. Viruses. 2023;15:2401. doi: 10.3390/v15122401.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15122401</ArticleId><ArticleId IdType="pmc">PMC10747620</ArticleId><ArticleId IdType="pubmed">38140642</ArticleId></ArticleIdList></Reference><Reference><Citation>Haystead T, Lee E, Cho K, Gullickson G, Hughes P, et al. Investigation of SARS-CoV-2 individual proteins reveals the in vitro and in vivo immunogenicity of membrane protein. Sci Rep. 2023;13:22873. doi: 10.1038/s41598-023-49077-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-49077-2</ArticleId><ArticleId IdType="pmc">PMC10739983</ArticleId><ArticleId IdType="pubmed">38129491</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande R, Li W, Li T, Fanning KV, Clemens Z, et al. SARS-CoV-2 accessory protein Orf7b induces lung injury via c-Myc mediated apoptosis and ferroptosis. Int J Mol Sci. 2024;25:1157. doi: 10.3390/ijms25021157.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25021157</ArticleId><ArticleId IdType="pmc">PMC10816122</ArticleId><ArticleId IdType="pubmed">38256231</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu T, Zhao S, Jin G, Song M, Zhi Y, et al. Cytokine signature induced by SARS-CoV-2 spike protein in a mouse model. Front Immunol. 2020;11:621441. doi: 10.3389/fimmu.2020.621441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.621441</ArticleId><ArticleId IdType="pmc">PMC7876321</ArticleId><ArticleId IdType="pubmed">33584719</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JS, Ru F, Meeker S, Undem BJ. Direct activation of airway sensory C-fibers by SARS-CoV-2 S1 spike protein. Physiol Rep. 2023;11:e15900. doi: 10.14814/phy2.15900.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.15900</ArticleId><ArticleId IdType="pmc">PMC10733116</ArticleId><ArticleId IdType="pubmed">38123162</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder JT, Bieneman AP. The S1 subunit of the SARS-CoV-2 spike protein activates human monocytes to produce cytokines linked to COVID-19: relevance to galectin-3. Front Immunol. 2022;13:831763. doi: 10.3389/fimmu.2022.831763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.831763</ArticleId><ArticleId IdType="pmc">PMC8982143</ArticleId><ArticleId IdType="pubmed">35392091</ArticleId></ArticleIdList></Reference><Reference><Citation>Biering SB, Gomes de Sousa FT, Tjang LV, Pahmeier F, Zhu C, et al. SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling. Nat Commun. 2022;13:7630. doi: 10.1038/s41467-022-34910-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34910-5</ArticleId><ArticleId IdType="pmc">PMC9734751</ArticleId><ArticleId IdType="pubmed">36494335</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K, Zhang Y, Hui X, Zhao Y, Gong W, et al. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice. EBioMedicine. 2021;67:103381. doi: 10.1016/j.ebiom.2021.103381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103381</ArticleId><ArticleId IdType="pmc">PMC8118724</ArticleId><ArticleId IdType="pubmed">33993052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Gu H, Cao L, Chen Q, Ye Q, et al. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nat Commun. 2021;12:5654. doi: 10.1038/s41467-021-25903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25903-x</ArticleId><ArticleId IdType="pmc">PMC8476561</ArticleId><ArticleId IdType="pubmed">34580297</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 2022;603:700–705. doi: 10.1038/s41586-022-04462-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04462-1</ArticleId><ArticleId IdType="pmc">PMC8942852</ArticleId><ArticleId IdType="pubmed">35104835</ArticleId></ArticleIdList></Reference><Reference><Citation>Cmielewski P, Anson DS, Parsons DW. Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length. Respir Res. 2010;11:84. doi: 10.1186/1465-9921-11-84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-11-84</ArticleId><ArticleId IdType="pmc">PMC2905357</ArticleId><ArticleId IdType="pubmed">20569421</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt F, Weisblum Y, Muecksch F, Hoffmann H-H, Michailidis E, et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020;217:e20201181. doi: 10.1084/jem.20201181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201181</ArticleId><ArticleId IdType="pmc">PMC7372514</ArticleId><ArticleId IdType="pubmed">32692348</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>